A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors
Clinical trial NCT02414516 · UNKNOWN
Trial details
- NCT number
- NCT02414516
- Sponsor
- Oncolys BioPharma Inc
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2019-06-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.